LYOPHILIZED LEVOSIMENDAN COMPOSITIONS
The invention relates to the pharmaceutical compositions in the form of the lyophilized powder, which do not contain alcohol, comprising Levosimendan as an active ingredient or a pharmaceutically acceptable salt thereof, Kollidon PF-17 as a solubilizing agent and tri-sodium citrate as a buffering ag...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ULUTURK, Celil FICICIOGLU, Samiye |
| description | The invention relates to the pharmaceutical compositions in the form of the lyophilized powder, which do not contain alcohol, comprising Levosimendan as an active ingredient or a pharmaceutically acceptable salt thereof, Kollidon PF-17 as a solubilizing agent and tri-sodium citrate as a buffering agent, preparation and use of these compositions.
L'invention concerne les compositions pharmaceutiques sous forme de poudre lyophilisée, qui ne contiennent pas d'alcool, comprenant du lévosimendan en tant que principe actif ou un sel pharmaceutiquement acceptable de celui-ci, du Kollidon PF-17 en tant qu'agent de solubilisation et du citrate trisodique en tant qu'agent tampon, la préparation et l'utilisation de ces compositions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023027670A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023027670A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023027670A23</originalsourceid><addsrcrecordid>eNrjZFD1ifQP8PD08YxydVHwcQ3zD_b0dfVzcfRTcPb3DQDyQjz9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxgZG5mbmBo5ExcaoAZPkksQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LYOPHILIZED LEVOSIMENDAN COMPOSITIONS</title><source>esp@cenet</source><creator>ULUTURK, Celil ; FICICIOGLU, Samiye</creator><creatorcontrib>ULUTURK, Celil ; FICICIOGLU, Samiye</creatorcontrib><description>The invention relates to the pharmaceutical compositions in the form of the lyophilized powder, which do not contain alcohol, comprising Levosimendan as an active ingredient or a pharmaceutically acceptable salt thereof, Kollidon PF-17 as a solubilizing agent and tri-sodium citrate as a buffering agent, preparation and use of these compositions.
L'invention concerne les compositions pharmaceutiques sous forme de poudre lyophilisée, qui ne contiennent pas d'alcool, comprenant du lévosimendan en tant que principe actif ou un sel pharmaceutiquement acceptable de celui-ci, du Kollidon PF-17 en tant qu'agent de solubilisation et du citrate trisodique en tant qu'agent tampon, la préparation et l'utilisation de ces compositions.</description><language>eng ; fre</language><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230302&DB=EPODOC&CC=WO&NR=2023027670A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230302&DB=EPODOC&CC=WO&NR=2023027670A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ULUTURK, Celil</creatorcontrib><creatorcontrib>FICICIOGLU, Samiye</creatorcontrib><title>LYOPHILIZED LEVOSIMENDAN COMPOSITIONS</title><description>The invention relates to the pharmaceutical compositions in the form of the lyophilized powder, which do not contain alcohol, comprising Levosimendan as an active ingredient or a pharmaceutically acceptable salt thereof, Kollidon PF-17 as a solubilizing agent and tri-sodium citrate as a buffering agent, preparation and use of these compositions.
L'invention concerne les compositions pharmaceutiques sous forme de poudre lyophilisée, qui ne contiennent pas d'alcool, comprenant du lévosimendan en tant que principe actif ou un sel pharmaceutiquement acceptable de celui-ci, du Kollidon PF-17 en tant qu'agent de solubilisation et du citrate trisodique en tant qu'agent tampon, la préparation et l'utilisation de ces compositions.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD1ifQP8PD08YxydVHwcQ3zD_b0dfVzcfRTcPb3DQDyQjz9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakl8uL-RgZGxgZG5mbmBo5ExcaoAZPkksQ</recordid><startdate>20230302</startdate><enddate>20230302</enddate><creator>ULUTURK, Celil</creator><creator>FICICIOGLU, Samiye</creator><scope>EVB</scope></search><sort><creationdate>20230302</creationdate><title>LYOPHILIZED LEVOSIMENDAN COMPOSITIONS</title><author>ULUTURK, Celil ; FICICIOGLU, Samiye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023027670A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>ULUTURK, Celil</creatorcontrib><creatorcontrib>FICICIOGLU, Samiye</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ULUTURK, Celil</au><au>FICICIOGLU, Samiye</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LYOPHILIZED LEVOSIMENDAN COMPOSITIONS</title><date>2023-03-02</date><risdate>2023</risdate><abstract>The invention relates to the pharmaceutical compositions in the form of the lyophilized powder, which do not contain alcohol, comprising Levosimendan as an active ingredient or a pharmaceutically acceptable salt thereof, Kollidon PF-17 as a solubilizing agent and tri-sodium citrate as a buffering agent, preparation and use of these compositions.
L'invention concerne les compositions pharmaceutiques sous forme de poudre lyophilisée, qui ne contiennent pas d'alcool, comprenant du lévosimendan en tant que principe actif ou un sel pharmaceutiquement acceptable de celui-ci, du Kollidon PF-17 en tant qu'agent de solubilisation et du citrate trisodique en tant qu'agent tampon, la préparation et l'utilisation de ces compositions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023027670A2 |
| source | esp@cenet |
| title | LYOPHILIZED LEVOSIMENDAN COMPOSITIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T10%3A09%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ULUTURK,%20Celil&rft.date=2023-03-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023027670A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |